Skip to main content
. 2024 Mar 24;6(8):101070. doi: 10.1016/j.jhepr.2024.101070

Fig. 2.

Fig. 2

Patient treatments and observations.

(A) Number of patients treated with BLV alone (black), BLV + Peg-IFN (red), Peg-IFN alone (orange) and off-treatment (blue). (B) Corresponding proportion of observations. Black bars correspond to detectable HDV RNA, gray bars represent undetectable HDV RNA, white bars represent the proportion of unavailable data at each time. BLV, bulevirtide; Peg-IFN, pegylated interferon.